Log in
Enquire now

List of Neumedicines Inc. patents

List of Neumedicines Inc. patents
List of Vuv Analytics, Inc. patents
List of Mist Systems patents
List of Cellular Research patents
Graphics venture capital investors
List of funding rounds for GLOBALEUR
Patents where
Current Assignee
Name
is
Neumedicines Inc.Neumedicines Inc.
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9636381 Methods for radiation protection by administering IL-12

Patent 9636381 was granted and assigned to Neumedicines Inc. on May, 2017 by the United States Patent and Trademark Office.

Neumedicines Inc.
Neumedicines Inc.
Neumedicines Inc.
Neumedicines Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9636381
May 2, 2017
‌
US Patent 9616106 IL-12 for radiation protection and radiation-induced toxicity mitigation

Patent 9616106 was granted and assigned to Neumedicines Inc. on April, 2017 by the United States Patent and Trademark Office.

Neumedicines Inc.
Neumedicines Inc.
Neumedicines Inc.
Neumedicines Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9616106
April 11, 2017
‌
US Patent 8735342 Method for treating brain cancer using a novel tumor suppressor gene and secreted factor

Patent 8735342 was granted and assigned to Neumedicines Inc. on May, 2014 by the United States Patent and Trademark Office.

Neumedicines Inc.
Neumedicines Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8735342
May 27, 2014
‌
US Patent 9925246 Mitigation of cutaneous injury with IL-12

Patent 9925246 was granted and assigned to Neumedicines Inc. on March, 2018 by the United States Patent and Trademark Office.

Neumedicines Inc.
Neumedicines Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9925246
March 27, 2018
‌
US Patent 9463219 Method for treating brain cancer using a novel tumor suppressor gene and secreted factor

Patent 9463219 was granted and assigned to Neumedicines Inc. on October, 2016 by the United States Patent and Trademark Office.

Neumedicines Inc.
Neumedicines Inc.
Neumedicines Inc.
Neumedicines Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9463219
October 11, 2016
‌
US Patent 8962317 Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration

Patent 8962317 was granted and assigned to Neumedicines Inc. on February, 2015 by the United States Patent and Trademark Office.

Neumedicines Inc.
Neumedicines Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8962317
February 24, 2015
‌
US Patent 9878012 IL-12 formulations for enhancing hematopoiesis

Patent 9878012 was granted and assigned to Neumedicines Inc. on January, 2018 by the United States Patent and Trademark Office.

Neumedicines Inc.
Neumedicines Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9878012
January 30, 2018
‌
US Patent 8921315 Method of increasing survival of a human subject having exposure to an acute exposure to non-therapeutic whole body ionization by administering a therapeutically effective dose of IL-12

Patent 8921315 was granted and assigned to Neumedicines Inc. on December, 2014 by the United States Patent and Trademark Office.

Neumedicines Inc.
Neumedicines Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8921315
December 30, 2014
‌
US Patent 8846392 Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration

Neumedicines Inc.
Neumedicines Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8846392
September 30, 2014
9 results
0 selected
9 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us